{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:28:56Z","timestamp":1794479336950,"version":"4.9.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"publisher","award":["QUCG-CPH-20_21\\u20134"],"award-info":[{"award-number":["QUCG-CPH-20_21\\u20134"]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"publisher","award":["QUST-2-CPH-2019\\u20135"],"award-info":[{"award-number":["QUST-2-CPH-2019\\u20135"]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"publisher","award":["QUST-1-CPH-2019\\u20131"],"award-info":[{"award-number":["QUST-1-CPH-2019\\u20131"]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.biopha.2026.119447","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:52:03Z","timestamp":1778100723000},"page":"119447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis and biological evaluation of novel chalcone analogs against castration-resistant prostate cancer"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7213-9077","authenticated-orcid":false,"given":"Ola J.","family":"Hussein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadeel","family":"Kheraldine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Elkhalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2012-4153","authenticated-orcid":false,"given":"Arij Fouzat","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2186-2518","authenticated-orcid":false,"given":"Hanan H.","family":"Abunada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8624-6869","authenticated-orcid":false,"given":"Feras","family":"Alali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala-Eddin Al","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119447_bib1","unstructured":"GLOBOCAN. Global Cancer Observatory (GCO): International Agency for Research on Cancer; 2020 [2020 August 15]. Available from: \u3008https:\/\/gco.iarc.fr\/\u3009."},{"key":"10.1016\/j.biopha.2026.119447_bib2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fonc.2019.00238","article-title":"Geographical variations in prostate cancer outcomes: a systematic review of international evidence","volume":"9","author":"Dasgupta","year":"2019","journal-title":"Front Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119447_bib3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","article-title":"International variation in prostate cancer incidence and mortality rates","volume":"61","author":"Center","year":"2012","journal-title":"Eur. Urol."},{"issue":"10013","key":"10.1016\/j.biopha.2026.119447_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(14)61947-4","article-title":"Prostate cancer","volume":"387","author":"Attard","year":"2016","journal-title":"Lancet"},{"issue":"32","key":"10.1016\/j.biopha.2026.119447_bib5","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1200\/JCO.18.00606","article-title":"Clinically localized prostate cancer: ASCO clinical practice guideline endorsement of an american urological association\/american society for radiation oncology\/society of urologic oncology guideline","volume":"36","author":"Bekelman","year":"2018","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119447_bib6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.juro.2017.11.095","article-title":"Clinically localized prostate cancer: AUA\/ASTRO\/SUO guideline. Part I: risk stratification, shared decision making, and care options","volume":"199","author":"Sanda","year":"2018","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119447_bib7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.critrevonc.2015.05.019","article-title":"Updated recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer","volume":"96","author":"Climent","year":"2015","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"key":"10.1016\/j.biopha.2026.119447_bib8","unstructured":"SEER. Cancer Stat Facts: Prostate Cancer: National Cancer Institute [2026 April 26]. Available from:\u00a0\u3008https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html\u3009."},{"issue":"3","key":"10.1016\/j.biopha.2026.119447_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ctrv.2012.09.005","article-title":"Progress in emerging therapies for advanced prostate cancer","volume":"39","author":"Oudard","year":"2013","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119447_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrclinonc.2010.136","article-title":"Drug resistance in metastatic castration-resistant prostate cancer","volume":"8","author":"Seruga","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119447_bib11","first-page":"109","article-title":"Current and emerging therapies for bone metastatic castration-resistant prostate cancer","volume":"22","author":"Frieling","year":"2015","journal-title":"Cancer Control J. Moffitt Cancer Center"},{"key":"10.1016\/j.biopha.2026.119447_bib12","unstructured":"Dawson NA, Leger P. Overview of the treatment of castration-resistant prostate cancer (CRPC). UpToDate. Wolters Kluwer; updated March 20, 2026. Available at: \u3008https:\/\/www.uptodate.com\/contents\/overview-of-the-treatment-of-castration-resistant-prostate-cancer-crpc\u3009. [2026 April 26]."},{"key":"10.1016\/j.biopha.2026.119447_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejmech.2015.05.004","article-title":"Anti-cancer chalcones: structural and molecular target perspectives","volume":"98","author":"Mahapatra","year":"2015","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.biopha.2026.119447_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111954","article-title":"Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer","volume":"187","author":"Elkhalifa","year":"2020","journal-title":"Eur. J. Med Chem."},{"issue":"24","key":"10.1016\/j.biopha.2026.119447_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262412082","article-title":"The role of natural chalcones and their derivatives in targeting prostate cancer: recent updates","volume":"26","author":"Hussein","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119447_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27002","article-title":"The effect of novel nitrogen-based chalcone analogs on colorectal cancer cells: insight into the molecular pathways","volume":"10","author":"Hassan","year":"2024","journal-title":"Heliyon"},{"issue":"21","key":"10.1016\/j.biopha.2026.119447_bib17","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3923\/pjbs.2013.1368.1372","article-title":"Synthesis and evaluation of chalcone analogues based pyrimidines as angiotensin converting enzyme inhibitors","volume":"16","author":"Bukhari","year":"2013","journal-title":"Pak. J. Biol. Sci. PJBS"},{"key":"10.1016\/j.biopha.2026.119447_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109315","article-title":"Antioxidant and anti-inflammatory effects of hesperidin methyl chalcone in experimental ulcerative colitis","volume":"333","author":"Guazelli","year":"2021","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.biopha.2026.119447_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/a-1296-7751","article-title":"Antimicrobial screening, in silico studies and QSAR of chalcone-based 1,4-disubstituted 1,2,3-triazole hybrids","volume":"71","author":"Yadav","year":"2021","journal-title":"Drug Res."},{"key":"10.1016\/j.biopha.2026.119447_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104630","article-title":"Design and synthesis of methoxyphenyl- and coumarin-based chalcone derivatives as anti-inflammatory agents by inhibition of NO production and down-regulation of NF-\u03baB in LPS-induced RAW264.7 macrophage cells","volume":"107","author":"Emam","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2026.119447_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118982","article-title":"Signaling pathways and proteins targeted by antidiabetic chalcones","volume":"284","author":"Adelusi","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2026.119447_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7651047","article-title":"Chalcone scaffold in anticancer armamentarium: a molecular insight","volume":"2016","author":"Das","year":"2016","journal-title":"J. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119447_bib23","first-page":"422","article-title":"Heterocyclic chalcone analogues as potential anticancer agents","volume":"13","author":"Sharma","year":"2013","journal-title":"Anti-cancer Agents Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119447_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1574892809666140819153902","article-title":"Advances in chalcones with anticancer activities","volume":"10","author":"Karthikeyan","year":"2015","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"6","key":"10.1016\/j.biopha.2026.119447_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065964","article-title":"Chalcones and gastrointestinal cancers: experimental evidence","volume":"24","author":"Michalkova","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119447_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.intimp.2010.12.006","article-title":"The role of chalcones in suppression of NF-\u03baB-mediated inflammation and cancer","volume":"11","author":"Yadav","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2026.119447_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fct.2015.11.016","article-title":"A novel quinazolinone chalcone derivative induces mitochondrial dependent apoptosis and inhibits PI3K\/Akt\/mTOR signaling pathway in human colon cancer HCT-116 cells","volume":"87","author":"Wani","year":"2016","journal-title":"Food. Chem. Toxicol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119447_bib28","first-page":"420","article-title":"The correlation between cancer incidence and kava consumption","volume":"59","author":"Steiner","year":"2000","journal-title":"Hawaii Med. J."},{"issue":"6","key":"10.1016\/j.biopha.2026.119447_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biom11060894","article-title":"Chalcone derivatives: role in anticancer therapy","volume":"11","author":"Ouyang","year":"2021","journal-title":"Biomolecules"},{"issue":"17","key":"10.1016\/j.biopha.2026.119447_bib30","doi-asserted-by":"crossref","first-page":"9621","DOI":"10.3390\/ijms22179621","article-title":"Novel nitrogen-based chalcone analogs provoke substantial apoptosis in HER2-positive human breast cancer cells via JNK and ERK1\/ERK2 signaling pathways","volume":"22","author":"Rizeq","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119447_bib31","unstructured":"A. Khalil, A. Al Moustafa, D. Elkhalifa, F. Alali, inventors. Novel chalcone-based chemotherapeutic compound for triple negative breast cancer. US 11,746,104 B2; September 5, 2023."},{"issue":"5","key":"10.1016\/j.biopha.2026.119447_bib32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/medicina55050206","article-title":"Anti-trypanosomal and antimalarial properties of tetralone derivatives and structurally related benzocycloalkanones","volume":"55","author":"Beteck","year":"2019","journal-title":"Medicina"},{"issue":"5","key":"10.1016\/j.biopha.2026.119447_bib33","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/cbdd.12990","article-title":"Antibacterial and antitubercular evaluation of dihydronaphthalenone-indole hybrid analogs","volume":"90","author":"Valmiki","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"issue":"4","key":"10.1016\/j.biopha.2026.119447_bib34","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/molecules25040986","article-title":"Synthesis and antiproliferative evaluation of novel longifolene-derived tetralone derivatives bearing 1,2,4-triazole moiety","volume":"25","author":"Zhu","year":"2020","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.biopha.2026.119447_bib35","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1021\/jm9806695","article-title":"Conformational and quantitative structure\u2212activity relationship study of cytotoxic 2-arylidenebenzocycloalkanones","volume":"42","author":"Dimmock","year":"1999","journal-title":"J. Med Chem."},{"issue":"14","key":"10.1016\/j.biopha.2026.119447_bib36","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1021\/jm010559p","article-title":"Correlations between cytotoxicity and topography of some 2-arylidenebenzocycloalkanones determined by X-ray crystallography","volume":"45","author":"Dimmock","year":"2002","journal-title":"J. Med Chem."},{"issue":"3","key":"10.1016\/j.biopha.2026.119447_bib37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1242\/bio.013409","article-title":"Changes in cell shape are correlated with metastatic potential in murine and human osteosarcomas","volume":"5","author":"Lyons","year":"2016","journal-title":"Biol. Open"},{"key":"10.1016\/j.biopha.2026.119447_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.932510","article-title":"Prostate cancer cells of increasing metastatic potential exhibit diverse contractile forces, cell stiffness, and motility in a microenvironment stiffness-dependent manner","volume":"10","author":"Molter","year":"2022","journal-title":"Front Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119447_bib39","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1530\/ERC-12-0285","article-title":"Current mouse and cell models in prostate cancer research","volume":"20","author":"Wu","year":"2013","journal-title":"Endocr. -Relat. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2026.119447_bib40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/ijms19020448","article-title":"Apoptosis: a target for anticancer therapy","volume":"19","author":"Pfeffer","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119447_bib41","first-page":"2022","article-title":"Elaeagnus angustifolia plant extract induces apoptosis via P53 and signal transducer and activator of transcription 3 signaling pathways in triple-negative breast cancer cells","volume":"9","author":"Fouzat","year":"2022"},{"issue":"5","key":"10.1016\/j.biopha.2026.119447_bib42","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3390\/cancers13050937","article-title":"Signaling pathways that control apoptosis in prostate cancer","volume":"13","author":"Ali","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biopha.2026.119447_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41421-021-00355-1","article-title":"Truncated PARP1 mediates ADP-ribosylation of RNA polymerase III for apoptosis","volume":"8","author":"Chen","year":"2022","journal-title":"Cell Discov."},{"issue":"1","key":"10.1016\/j.biopha.2026.119447_bib44","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s43556-025-00385-1","article-title":"PARPs and PARP inhibitors: molecular mechanisms and clinical applications","volume":"6","author":"Wang","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.biopha.2026.119447_bib45","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.biopha.2018.06.153","article-title":"A novel synthesized 3\u2019, 5\u2019-diprenylated chalcone mediates the proliferation of human leukemia cells by regulating apoptosis and autophagy pathways","volume":"106","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119447_bib46","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ejmech.2018.08.069","article-title":"5'-Chloro-2,2\u2032-dihydroxychalcone and related flavanoids as treatments for prostate cancer","volume":"157","author":"Saito","year":"2018","journal-title":"Eur. J. Med Chem."},{"issue":"3","key":"10.1016\/j.biopha.2026.119447_bib47","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1021\/acs.jnatprod.5b00908","article-title":"Texas native plants yield compounds with cytotoxic activities against prostate cancer cells","volume":"79","author":"Shaffer","year":"2016","journal-title":"J. Nat. Prod."},{"issue":"17","key":"10.1016\/j.biopha.2026.119447_bib48","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1016\/j.bmc.2017.07.031","article-title":"Synthesis of different heterocycles-linked chalcone conjugates as cytotoxic agents and tubulin polymerization inhibitors","volume":"25","author":"Shankaraiah","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119447_bib49","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbrc.2004.07.094","article-title":"Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells","volume":"322","author":"Fu","year":"2004","journal-title":"Biochem Biophys. Res Commun."},{"issue":"12","key":"10.1016\/j.biopha.2026.119447_bib50","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1158\/1541-7786.MCR-10-0568","article-title":"Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation","volume":"9","author":"Yao","year":"2011","journal-title":"Mol. Cancer Res. MCR"},{"issue":"3","key":"10.1016\/j.biopha.2026.119447_bib51","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0008-6363(99)00384-3","article-title":"Pulkki K. Morphologic and biochemical hallmarks of apoptosis","volume":"45","author":"Saraste","year":"2000","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/j.biopha.2026.119447_bib52","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1073\/pnas.72.11.4435","article-title":"Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro","volume":"72","author":"Shin","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"19","key":"10.1016\/j.biopha.2026.119447_bib53","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2024.39.e156","article-title":"Anchorage dependence and cancer metastasis","volume":"39","author":"Lee","year":"2024","journal-title":"J. Korean Med Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119447_bib54","first-page":"156","article-title":"p21WAF1 regulates anchorage-independent growth of HCT116 colon carcinoma cells via E-cadherin Expression1","volume":"60","author":"Mueller","year":"2000","journal-title":"Cancer Res."},{"issue":"6 16","key":"10.1016\/j.biopha.2026.119447_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/sonc.2002.37263","article-title":"Role of angiogenesis in tumor growth and metastasis","volume":"29","author":"Folkman","year":"2002","journal-title":"Semin. Oncol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119447_bib56","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.3390\/ijms20112676","article-title":"Targeting angiogenesis in prostate cancer","volume":"20","author":"Melegh","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119447_bib57","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.tiv.2010.08.002","article-title":"Butein suppresses the expression of nuclear factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate cancer cells","volume":"24","author":"Moon","year":"2010","journal-title":"Toxicol. Vitro Int. J. Publ. Assoc. BIBRA"},{"key":"10.1016\/j.biopha.2026.119447_bib58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/mTOR signaling in cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front.Oncol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119447_bib59","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.3390\/ijms21124507","article-title":"The PI3K-AKT-mTOR pathway and prostate cancer: at the crossroads of AR, MAPK, and WNT signaling","volume":"21","author":"Shorning","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119447_bib60","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/2159-8290.CD-17-0867","article-title":"Identification of Pik3ca mutation as a genetic driver of prostate cancer that cooperates with Pten loss to accelerate progression and castration-resistant growth","volume":"8","author":"Pearson","year":"2018","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.biopha.2026.119447_bib61","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ccr.2011.04.008","article-title":"Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer","volume":"19","author":"Carver","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2026.119447_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109679","article-title":"The role of JNK in prostate cancer progression and therapeutic strategies","volume":"121","author":"Xu","year":"2020","journal-title":"Biomed. Pharmacother."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600483X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600483X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:43:15Z","timestamp":1794476595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222600483X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":62,"alternative-id":["S075333222600483X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119447","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of novel chalcone analogs against castration-resistant prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119447"}}